A prescription blood-pressure and diuretic drug with anti-androgen effects, used off-label mainly by women for pattern hair loss.
A topical antiandrogen sold as a cosmetic (Eucapil), tested in one small 2002 trial in men.
A nonsteroidal antiandrogen licensed for prostate cancer; sometimes prescribed off-label for female pattern hair loss, with liver monitoring. Not for use in pregnancy.
Pyrilutamide (KX-826) is an investigational topical antiandrogen. It is not approved anywhere, and its trial results, including a failed 2023 Phase III and a positive 2026 one, are sponsor-reported and not peer-reviewed.
A stronger DHT blocker than finasteride, approved for hair loss only in South Korea and Japan and off-label elsewhere, with the same class of side effects and a much longer washout.